BioPorto | BIOPOR Logo | Annual Report & Investor Relations Data

BioPorto | BIOPOR Annual Report & Investor Relations Data

ISIN

DK0011048619

Ticker

BIOPOR

Sector

Health Care

Industry

Biotechnology

Country

Denmark

Year Founded

BioPorto (BIOPOR)
Company Overview & Profile

Company Description

BioPorto is an in vitro diagnostics company focused on saving lives and improving the quality of life with actionable biomarkers – tools designed to help clinicians make changes in patient management. The Company uses its expertise in antibodies and assay development, as well as its platform for assay development, to create a pipeline of novel and compelling products that focus on conditions where there is a significant unmet medical need, and where the Company’s tests can help improve clinical and economic outcomes for patients, providers, and the healthcare ecosystem.

The Company’s flagship product is The NGAL Test, which has been designed to aid in the risk assessment of Acute Kidney Injury (AKI), a common clinical syndrome that can have severe consequences, including significant morbidity and mortality if not identified and treated early.

Headquarters

Tuborg Havnevej 15
2900, Hellerup
Denmark

BioPorto (BIOPOR)
Filings & Annual Reports

Filters

View all types
Type Document Details Language Filing Date File Number

Get API Access

Access comprehensive European stock market filings data through a single, powerful API.

1,5M+

filings covered

18

European countries

30min

max latency

1 API

for all filings

BioPorto (BIOPOR)
Leadership: Management & Supervisory Board

No Leadership Information Available

We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.

BioPorto (BIOPOR)
Stock & Investor Information

ISIN

DK0011048619

LEI

5299004SWFL5JAN4W830

Stock Exchange Listings

Nasdaq Copenhagen

Industry Classification

BioPorto (BIOPOR)
Related Companies & Peer Group

4SC AG Logo

4SC AG

VSC

Sector

Health Care

Country

Germany

ISIN

DE000A3E5C40

Founded

1997

4SC focuses on the development of novel small molecule drugs that target key mechanisms of cancer development, such as histone …

ABIONYX Pharma Logo

ABIONYX Pharma

ABNX

Sector

Health Care

Country

France

ISIN

FR0012616852

Founded

ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there …

Abliva Logo

Abliva

ABLI

Sector

Health Care

Country

Sweden

ISIN

SE0002575340

Founded

2000

Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when …

AB Science Logo

AB Science

AB

Sector

Health Care

Country

France

ISIN

FR0010557264

Founded

2001

AB Science is a late-clinical-stage French company founded in 2001 by a team of scientists with the goal of developing …

Acticor Biotech Logo

Acticor Biotech

ALACT

Sector

Health Care

Country

France

ISIN

FR0014005OJ5

Founded

Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of …

Active Biotech Logo

Active Biotech

ACTI

Sector

Health Care

Country

Sweden

ISIN

SE0001137985

Founded

1998

Active Biotech develops pharmaceutical products within medical areas where the immune system is of significant importance, including cancer and inflammatory …